The FDA has marked today’s international Rare Disease Day with a number of measures to promote research and patient participation in policy and research.
A new study has added to data suggesting that HDL cholesterol (HDL-c) – sometimes called ‘good’ cholesterol as it can help protect against heart disease – may be a risk fa
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio